FdaApplication
NDA 218591
Identifiers
- fda_app_no: NDA218591
Properties
| Property | Value |
|---|---|
| applicant_name | NOVARTIS PHARMACEUTICALS CORP |
| application_type | NDA |
| approval_date | 2024-04-12 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ENTRESTO SPRINKLE | SACUBITRIL; VALSARTAN | 6MG;6MG | CAPSULE, PELLETS;ORAL |
| ENTRESTO SPRINKLE | SACUBITRIL; VALSARTAN | 15MG;16MG | CAPSULE, PELLETS;ORAL |
2 products